Literature DB >> 19375891

Naturally-existing CD4(+)CD25(+)Foxp3(+) regulatory T cells are required for tolerance to experimental autoimmune thyroiditis induced by either exogenous or endogenous autoantigen.

Gerald P Morris1, Nicholas K Brown, Yi-chi M Kong.   

Abstract

Murine experimental autoimmune thyroiditis (EAT) is a model for Hashimoto's thyroiditis, an organ-specific autoimmune disease characterized by mononuclear cell infiltration and destruction of the thyroid gland. Susceptibility to EAT is MHC-linked, and influenced by CD4(+)CD25(+)Foxp3(+) regulatory T cells (Tregs). Treg depletion enables thyroiditis induction with mouse thyroglobulin (mTg) in traditionally-resistant mice and mTg-induced, Treg-mediated tolerance protects against EAT induction in genetically-susceptible mice. Here, we demonstrate the existence of naturally-existing CD4(+)CD25(+)Foxp3(+) Tregs (nTregs) influencing thyroiditis development in naive susceptible mice and that induction of thyroiditis in these mice involves overcoming peripheral homeostatic immune suppression by nTregs. Additionally we demonstrate that nTregs are required for induction of antigen-specific tolerance, indicating that induced EAT tolerance is a result of activation of naturally-existing nTregs rather than de novo generation of induced Tregs (iTregs). Examination of several potential costimulatory molecules previously described as involved in peripheral activation of Tregs demonstrates a critical role indeed for CTLA-4 in the activation of nTregs leading to development of EAT tolerance and providing a mechanism for mTg-induced Treg activation during tolerance induction. Together, these data reinforce the important role of Tregs in mediating self-tolerance, and illuminate a potential mechanism for their therapeutic expansion in induced tolerance.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19375891      PMCID: PMC2706097          DOI: 10.1016/j.jaut.2009.03.010

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  54 in total

1.  CD40/CD40L interaction regulates CD4+CD25+ T reg homeostasis through dendritic cell-produced IL-2.

Authors:  Cristiana Guiducci; Barbara Valzasina; Heidrun Dislich; Mario P Colombo
Journal:  Eur J Immunol       Date:  2005-02       Impact factor: 5.532

2.  Specific blockade of CTLA-4/B7 interactions results in exacerbated clinical and histologic disease in an actively-induced model of experimental allergic encephalomyelitis.

Authors:  A A Hurwitz; T J Sullivan; M F Krummel; R A Sobel; J P Allison
Journal:  J Neuroimmunol       Date:  1997-03       Impact factor: 3.478

3.  Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement.

Authors:  V L Perez; L Van Parijs; A Biuckians; X X Zheng; T B Strom; A K Abbas
Journal:  Immunity       Date:  1997-04       Impact factor: 31.745

4.  H2A- and H2E-derived CD4+CD25+ regulatory T cells: a potential role in reciprocal inhibition by class II genes in autoimmune thyroiditis.

Authors:  Gerald P Morris; Yan Yan; Chella S David; Yi-Chi M Kong
Journal:  J Immunol       Date:  2005-03-01       Impact factor: 5.422

5.  Administration of anti-interleukin-2 receptor alpha antibody in vivo induces localized autoimmune disease.

Authors:  O Taguchi; T Takahashi
Journal:  Eur J Immunol       Date:  1996-07       Impact factor: 5.532

6.  IL-10-producing CD4+CD25+ regulatory T cells play a critical role in granulocyte-macrophage colony-stimulating factor-induced suppression of experimental autoimmune thyroiditis.

Authors:  Eryn Gangi; Chenthamarakshan Vasu; Donald Cheatem; Bellur S Prabhakar
Journal:  J Immunol       Date:  2005-06-01       Impact factor: 5.422

7.  Regulatory T cell lineage specification by the forkhead transcription factor foxp3.

Authors:  Jason D Fontenot; Jeffrey P Rasmussen; Luke M Williams; James L Dooley; Andrew G Farr; Alexander Y Rudensky
Journal:  Immunity       Date:  2005-03       Impact factor: 31.745

8.  Primary hormonogenic sites as conserved autoepitopes on thyroglobulin in murine autoimmune thyroiditis. Secondary role of iodination.

Authors:  Y C Kong; D J McCormick; Q Wan; R W Motte; B E Fuller; A A Giraldo; C S David
Journal:  J Immunol       Date:  1995-12-15       Impact factor: 5.422

9.  Conversion of CD4+ CD25- cells into CD4+ CD25+ regulatory T cells in vivo requires B7 costimulation, but not the thymus.

Authors:  Shuang Liang; Pascale Alard; Yuan Zhao; Sarah Parnell; Sherry L Clark; Michele M Kosiewicz
Journal:  J Exp Med       Date:  2005-01-03       Impact factor: 14.307

10.  Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization.

Authors:  Ruka Setoguchi; Shohei Hori; Takeshi Takahashi; Shimon Sakaguchi
Journal:  J Exp Med       Date:  2005-03-07       Impact factor: 14.307

View more
  24 in total

Review 1.  Immunity, thyroid function and pregnancy: molecular mechanisms.

Authors:  Anthony P Weetman
Journal:  Nat Rev Endocrinol       Date:  2010-04-27       Impact factor: 43.330

2.  A contemporary update on scleroderma.

Authors:  Loïc Guillevin
Journal:  Clin Rev Allergy Immunol       Date:  2011-04       Impact factor: 8.667

3.  Efficacy of HLA-DRB1∗03:01 and H2E transgenic mouse strains to correlate pathogenic thyroglobulin epitopes for autoimmune thyroiditis.

Authors:  Yi-chi M Kong; Nicholas K Brown; Jeffrey C Flynn; Daniel J McCormick; Vladimir Brusic; Gerald P Morris; Chella S David
Journal:  J Autoimmun       Date:  2011-06-17       Impact factor: 7.094

Review 4.  Thyroid dysfunctions secondary to cancer immunotherapy.

Authors:  P Chalan; G Di Dalmazi; F Pani; A De Remigis; A Corsello; P Caturegli
Journal:  J Endocrinol Invest       Date:  2017-12-13       Impact factor: 4.256

Review 5.  Immunotoxicity from checkpoint inhibitor therapy: clinical features and underlying mechanisms.

Authors:  Petros Fessas; Lucia A Possamai; James Clark; Ella Daniels; Cathrin Gudd; Benjamin H Mullish; James L Alexander; David J Pinato
Journal:  Immunology       Date:  2019-11-19       Impact factor: 7.397

Review 6.  Opportunistic autoimmune disorders: from immunotherapy to immune dysregulation.

Authors:  Yi-chi M Kong; Wei-Zen Wei; Yaron Tomer
Journal:  Ann N Y Acad Sci       Date:  2010-01       Impact factor: 5.691

7.  Sensitization to gliadin induces moderate enteropathy and insulitis in nonobese diabetic-DQ8 mice.

Authors:  Heather J Galipeau; Nestor E Rulli; Jennifer Jury; Xianxi Huang; Romina Araya; Joseph A Murray; Chella S David; Fernando G Chirdo; Kathy D McCoy; Elena F Verdu
Journal:  J Immunol       Date:  2011-09-12       Impact factor: 5.422

Review 8.  Breaking tolerance to thyroid antigens: changing concepts in thyroid autoimmunity.

Authors:  Sandra M McLachlan; Basil Rapoport
Journal:  Endocr Rev       Date:  2013-12-04       Impact factor: 19.871

9.  Enhanced autoimmunity associated with induction of tumor immunity in thyroiditis-susceptible mice.

Authors:  Suresh Kari; Jeffrey C Flynn; Muhammad Zulfiqar; Daniel P Snower; Bruce E Elliott; Yi-chi M Kong
Journal:  Thyroid       Date:  2013-09-11       Impact factor: 6.568

Review 10.  Autoimmune thyroiditis: a model uniquely suited to probe regulatory T cell function.

Authors:  Yi-Chi M Kong; Gerald P Morris; Nicholas K Brown; Yan Yan; Jeffrey C Flynn; Chella S David
Journal:  J Autoimmun       Date:  2009-10-12       Impact factor: 7.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.